Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K
GPCR Desensitization01:12

GPCR Desensitization

7.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.6K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

13.7K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.7K
The Two-State Receptor Model01:29

The Two-State Receptor Model

2.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.9K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

3.5K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addendum: In situ architecture of the human prohibitin complex.

Nature cell biology·2026
Same author

Developmental emergence of sparse and structured synaptic connectivity in the hippocampal CA3 memory circuit.

Nature communications·2026
Same author

Pathological TDP-43 filaments accumulate at synapses and cause synaptic dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Structure and organization of AMPA receptor-TARP complexes in the mammalian cerebellum.

Science (New York, N.Y.)·2025
Same author

Design and Synthesis of Pyrazoline Inhibitors of SARS-CoV‑2 NSP14.

ACS medicinal chemistry letters·2025
Same author

'Mini analysis' misrepresents changes in synaptic properties due to incomplete event detection.

The Journal of physiology·2025

Related Experiment Video

Updated: Dec 13, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K

Characterizing the binding and function of TARP γ8-selective AMPA receptor modulators.

Jan-Niklas Dohrke1, Jake F Watson1, Kristian Birchall2

  • 1Neurobiology Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.

The Journal of Biological Chemistry
|August 5, 2020
PubMed
Summary

Researchers identified how epilepsy drugs target brain receptors. A key molecular feature, the oxindole isostere, binds to TARP γ8, enabling region-specific epilepsy therapeutics by modulating alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Keywords:
AMPA receptorMD simulationselectrophysiologyglutamate receptorionotropic glutamate receptorsynapseα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor, AMPAR)

More Related Videos

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

7.9K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.3K

Related Experiment Videos

Last Updated: Dec 13, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.9K
A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

7.9K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.3K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Structural Biology

Background:

  • Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) are crucial for brain function, mediating synaptic transmission and plasticity.
  • Dysregulation of AMPARs is implicated in neurological disorders, notably epilepsy, due to excessive receptor activation.
  • Transmembrane AMPAR regulatory proteins (TARPs), particularly TARP γ8, modulate AMPAR function and are regionally expressed, presenting opportunities for targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which novel therapeutic compounds selectively target AMPAR/TARP γ8 complexes.
  • To understand how these modulators interact with the receptor complex to inform the development of refined epilepsy treatments.

Main Methods:

  • Computational approaches including ligand docking and molecular dynamics simulations.
  • Electrophysiological recordings to assess functional modulation of AMPAR/TARP complexes.

Main Results:

  • A conserved oxindole isostere was identified as a key structural motif responsible for engaging TARP γ8 via hydrogen bonding to Asn-172.
  • Variable regions of the modulators interact with the receptor complex in ligand-specific manners.
  • Functional studies demonstrated similar modulatory actions for prominent compounds, validating the identified binding interactions.

Conclusions:

  • The study reveals the precise molecular interactions underlying selective AMPAR/TARP γ8 modulation by novel epilepsy drug candidates.
  • Findings provide a structural basis for designing improved, region-specific therapeutics for epilepsy and other neurological conditions.
  • This work advances the understanding of TARP-mediated regulation of AMPARs, crucial for neurological function and disease.